Regency Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-170
Closed -$39K 153
2021
Q3
$39K Buy
+170
New +$42K 0.03% 92
2021
Q2
Sell
-1,510
Closed -$282K 157
2021
Q1
$282K Buy
+1,510
New +$295K 0.3% 68

Other funds holding LLY

Regency Capital Management's LLY Position: Q4 2021 in Review

Regency Capital Management sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 170 shares — an estimated $39K sold.

Regency Capital Management first reported a position in LLY in Q1 2021 and held it in 2 quarters. The position peaked at $282K in Q1 2021. 2,304 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • Regency Capital Management reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • Regency Capital Management sold 170 Eli Lilly shares in Q4 2021, an estimated $39K.
  • Regency Capital Management first reported a position in Eli Lilly in Q1 2021 and held it in 2 quarters.
  • Regency Capital Management's Eli Lilly position peaked at $282K in Q1 2021.
  • 2,304 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Regency Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.